162 related articles for article (PubMed ID: 18511177)
1. The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.
Schröder F; Kattan MW
Eur Urol; 2008 Aug; 54(2):274-90. PubMed ID: 18511177
[TBL] [Abstract][Full Text] [Related]
2. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
Lee A; Lim J; Gao X; Liu L; Chia SJ
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy.].
Murray NP; Fuentealba C; Reyes E; Jacob O
Arch Esp Urol; 2017 Jun; 70(5):503-512. PubMed ID: 28613202
[TBL] [Abstract][Full Text] [Related]
4. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
[TBL] [Abstract][Full Text] [Related]
5. The outcomes of transrectal ultrasound guided biopsy of the prostate in a New Zealand population.
Lienert AR; Davidson PJ; Wells JE
N Z Med J; 2009 Jan; 122(1288):39-49. PubMed ID: 19182841
[TBL] [Abstract][Full Text] [Related]
6. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
[TBL] [Abstract][Full Text] [Related]
7. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
Karakiewicz PI; Benayoun S; Kattan MW; Perrotte P; Valiquette L; Scardino PT; Cagiannos I; Heinzer H; Tanguay S; Aprikian AG; Huland H; Graefen M
J Urol; 2005 Jun; 173(6):1930-4. PubMed ID: 15879784
[TBL] [Abstract][Full Text] [Related]
9. Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
Nowroozi MR; Amini S; Kasaeian A; Zavarehei MJ; Eshraghian MR; Ayati M
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e289-97. PubMed ID: 24684767
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction.
Oliveira M; Marques V; Carvalho AP; Santos A
BJU Int; 2011 Jun; 107(11):1780-3. PubMed ID: 20883487
[TBL] [Abstract][Full Text] [Related]
11. The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.
Shen P; Zhao J; Sun G; Chen N; Zhang X; Gui H; Yang Y; Liu J; Shu K; Wang Z; Zeng H
Andrology; 2017 May; 5(3):548-555. PubMed ID: 28409907
[TBL] [Abstract][Full Text] [Related]
12. A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy.
Sun J; Zhang Z; OuYang J
Urol Oncol; 2020 May; 38(5):401-409. PubMed ID: 31870724
[TBL] [Abstract][Full Text] [Related]
13. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
Thompson IM; Ankerst DP; Chi C; Lucia MS; Goodman PJ; Crowley JJ; Parnes HL; Coltman CA
JAMA; 2005 Jul; 294(1):66-70. PubMed ID: 15998892
[TBL] [Abstract][Full Text] [Related]
14. A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy.
Ouzaid I; Yates DR; Hupertan V; Mozer P; Chartier-Kastler E; Haertig A; Bitker MO; Rouprêt M
Prostate; 2012 Aug; 72(11):1200-6. PubMed ID: 22213470
[TBL] [Abstract][Full Text] [Related]
15. External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer.
Roumiguié M; Beauval JB; Filleron T; Benoit T; Rischmann P; de la Taille A; Salomon L; Soulié M; Malavaud B; Ploussard G
BJU Int; 2014 Dec; 114(6b):E113-E119. PubMed ID: 24684584
[TBL] [Abstract][Full Text] [Related]
16. The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Jpn J Clin Oncol; 2004 Oct; 34(10):602-7. PubMed ID: 15591458
[TBL] [Abstract][Full Text] [Related]
17. Head to Head Comparison of the Chun Nomogram, Percentage Free PSA and Primary Circulating Prostate Cells to Predict the Presence of Prostate Cancer at Repeat Biopsy.
Murray NP; Reyes E; Orellana N; Fuentealba C; Jacob O
Asian Pac J Cancer Prev; 2016; 17(6):2941-6. PubMed ID: 27356715
[TBL] [Abstract][Full Text] [Related]
18. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.
Suzuki H; Komiya A; Kamiya N; Imamoto T; Kawamura K; Miura J; Suzuki N; Nakatsu H; Hata A; Ichikawa T
Urology; 2006 Jan; 67(1):131-6. PubMed ID: 16413348
[TBL] [Abstract][Full Text] [Related]
19. Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancer.
Murray NP; Reyes E; Fuentealba C; Orellana N; Jacob O; Badilla S
Urol Oncol; 2015 May; 33(5):203.e19-25. PubMed ID: 25746939
[TBL] [Abstract][Full Text] [Related]
20. Nomograms and instruments for the initial prostate evaluation: the ability to estimate the likelihood of identifying prostate cancer.
Ohori M; Swindle P
Semin Urol Oncol; 2002 May; 20(2):116-22. PubMed ID: 12012297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
